(Photo=LG) Nvidia’s next growth frontier is beginning to take shape far beyond the data center. As artificial intelligence moves into factories, robots and vehicles, the chipmaker is deepening ties with LG Group, the South Korean industrial conglomerate whose businesses span electronics, batteries, automotive components, information technology services and manufacturing. LG Group Chairman Koo Kwang mo is expected to meet Nvidia

(Photo=Pixabay) South Korea’s import prices fell for a second straight month in July as lower oil prices and a stronger won reduced the cost of energy and raw materials brought into the country.  The decline offers an early sign that some of the inflation pressure weighing on one of Asia’s largest manufacturing economies may be starting to ease, even though

Photo=Motionelements Gold’s resurgence is giving U.S. investors another reason to watch demand for bullion ETFs globally, as central banks increasingly turn to exchange-traded products to gain exposure to the metal. South Korea’s central bank has joined that trend, disclosing a roughly $250 million position in the world’s largest gold ETF The Bank of Korea disclosed on August 12 that it

Photo=Celltrion The U.S. market for antibody-drug conjugates is drawing increasing attention from drugmakers and investors as pharmaceutical companies seek more targeted cancer therapies, and Celltrion is expanding its presence in the field with a pipeline of candidates aimed at tumors that remain difficult to treat. Celltrion said its CT-P73, an ADC designed to target tissue factor, has received Fast Track

(Photo=JW Pharmaceutical Corporation) For millions of Americans and global patients suffering from the debilitating pain of gout, treatment options have long been constrained by safety concerns and limited efficacy. Now, South Korea’s JW Pharmaceutical is accelerating the commercialization of its novel gout drug candidate, Epaminurad, bringing a 16-year development journey closer to the finish line. The Seoul-based drugmaker announced plans